Has New York’s Mayor Giuliani
spread his misinformed animosity for methadone to Arizona? Former POW,
current U.S. Senator, and probable presidential candidate John McCain (Republican,
Arizona) introduced a bill during the 1998-99 session which would, if it had been made law, kill medicaid
funding for any MMT that maintained patients for longer than 6 months. NAMA thinks that patients should know about Presidential candidates whose ideas jeopardize their lives.
Read it and weep…
Mistake
On February 11, 1999 Senator John McCain
(R AZ) introduced Senate Bill 423
the “Addiction Free Treatment Act of
1999”.
The intent of S423 is to admonish the
administrations announcement by
McCaffery in late September to expand
methadone treatment and to allow
physicians to prescribe methadone from
their office. It is politically
motivated, however you will see by its
tenor that the Resolution is
primarily an insult to methadone patients
themselves.
Response to Senator McCain
S423
VERSION: INTRODUCED IN SENATE
Feb. 11, 1999
106TH CONGRESS
1ST SESSION
S. 423
To prohibit certain Federal payments
for certain methadone maintenance
programs, and for other purposes.
=======================
IN THE SENATE OF THE UNITED STATES
February 11, 1999
Mr. MCCAIN introduced the following bill;
which was read twice and referred to the Committee on Finance
=======================
A BILL
To prohibit certain Federal payments
for certain methadone maintenance
programs, and for other purposes.
Be it enacted by the Senate and House
of Representatives of the United
States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Addiction
Free Treatment Act of 1999”.
SEC. 2. FINDINGS.
Congress makes the following findings:
(1) Heroin use in the United States
continues to increase.
(2) Drug use among teenagers in the
United States is increasing and the
number of teenagers that are using heroin
for the first time is higher than
at any previous time in history.
(3) Between 1992 and 1996 heroin use
among college-age students increased
an estimated 10 percent.
(4) There are an estimated 810,000 chronic
heroin users in the United
States, with an estimated 115,000 heroin
addicts in the United States
currently participating in methadone
programs.
(5) Methadone is a synthetic opiate
and the use of methadone in the
treatment of heroin addiction results
in the transfer of addiction from 1
narcotic to another.
(6) Methadone addicts attempting detoxification
experience the same
difficult withdrawal process as would
be experienced with heroin
detoxification.
(7) The Federal Government should adopt
a zero-tolerance,
non-pharmacological policy that has
as its defined objective Independence
from drug addiction.
(8) The approach of the Federal Government
should be to address a range of
human needs and conditions that contribute
to recidivism among recovering
heroin addicts and that should be designed
to provide opportunities for
former heroin addicts to become drug-free,
self-sufficient, productive
members of society.
SEC. 3. PROHIBITION ON THE USE OF MEDICAID
FUNDS FOR CERTAIN
METHADONE MAINTENANCE PROGRAMS.
Section 1903(i) of the Social Security
Act (42 U.S.C. 1396b(i)) is
amended–
(1) in paragraph (18), by striking
the period and inserting “; or”; and
(2) by adding at the end the following:
“(19) with respect to any amount expended
for any drug treatment or
rehabilitation program that utilizes
methadone or Levo-Alpha
Acetyl-Methadol unless the program–
“(A) has as its primary objective
the elimination of drug addiction,
including addiction to methadone or
Levo-Alpha Acetyl-Methadol;
“(B) has a specifically defined
timetable (not to exceed 6 months from the
date of an individual’s enrollment as
a patient in the program) for
achieving complete termination of methadone
or Levo-Alpha Acetyl-Methadol
treatment;
“(C) conducts random and
frequent comprehensive drug testing for all
narcotics;
“(D) provides documentation
of the results of such testing;
“(E) requires that patients
who are participating in the program be
drug-free for the duration of their
methadone or Levo-Alpha Acetyl-Methadol
treatment; and
“(F) terminates the methadone
or Levo-Alpha Acetyl-Methadol treatment of
any patient who tests positive for any
other illegal narcotic during the
duration of their methadone or Levo-Alpha
Acetyl-Methadol treatment.”.
SEC. 4. PROHIBITION ON THE USE OF CERTAIN
PUBLIC HEALTH SERVICE
ACT FUNDS FOR CERTAIN METHADONE
MAINTENANCE PROGRAMS.
Section 501 of the Public Health Service
Act (42 U.S.C. 290aa) is amended
by adding at the end the following:
“(n) LIMITATION.–Notwithstanding any
other provision of law, amounts
appropriated under this title or title
XIX and administered by the
Substance Abuse and Mental Health Services
Administration may not be
expended for any drug treatment or rehabilitation
program that utilizes
methadone or Levo-Alpha Acetyl-Methadol
unless the program–
“(1) has as its primary objective
the elimination of drug addiction,
including addiction to methadone or
Levo-Alpha Acetyl-Methadol;
“(2) has a specifically defined
timetable (not to exceed 6 months from the
date of an individual’s enrollment as
a patient in the program) for
achieving complete termination of methadone
or Levo-Alpha Acetyl-Methadol
treatment;
“(3) conducts random and frequent
comprehensive drug testing for all
narcotics;
“(4) provides documentation of
the results of such testing;
“(5) requires that patients who
are participating in the program be
drug-free for the duration of their
methadone or Levo-Alpha Acetyl-Methadol
treatment; and
“(6) terminates the methadone
or Levo-Alpha Acetyl-Methadol treatment of
any patient who tests positive for any
other illegal narcotic during the
duration of their methadone or Levo-Alpha
Acetyl-Methadol treatment.”.
SEC. 5. STUDY OF TREATMENT PROGRAMS.
Not later than 3 years after the date
of enactment of this Act, the
Director of the National Institute of
Drug Abuse shall have conducted and
completed a study concerning–
(1) the methods and effectiveness
of nonpharmacological heroin
rehabilitation programs; and
(2) the methods and effectiveness
of methadone-to-abstinence programs.
SEC. 6. ANNUAL REPORT ON EFFECTIVENESS
OF HEROIN REHABILITATION
PROGRAMS.
(a) IN GENERAL.–Not later than
January 1, 2000, and each January 1
thereafter, the Secretary of Health
and Human Services acting through the
Center for Substance Abuse Treatment
shall prepare and submit to Congress a
report concerning the effectiveness
of heroin rehabilitation programs. Each
such report shall focus on both nonpharmacological
and
methadone-to-abstinence based approaches
to heroin rehabilitation.
(b) TERMINATION.–The requirement
under subsection (a) shall terminate
after the Secretary of Health and Human
Services submits the 5th annual
report under such subsection.
SEC. 7. EFFECTIVE DATE.
The amendments made by this Act apply
to amounts expended on and after the
date that is 6 months after the date
of enactment of this Act.
Last Update: February 6, 2000 |
News ![]() |
Home ![]() |
---|